The Biotech Intelligence Brief: guest pitching info, reach and format

Should you pitch it?

Guest activity

Sometimes has guests

25% of recent episode titles look like interviews

Episode length

21 min

Median of recent episodes. That is the commitment you would be asking for.

Publishing

Monthly

8 episodes · last 2026-07-10

Language

Not stated

This feed declares no language.

Where it's from

Not established

No .uk domain and no region in the feed language. Apple reports the storefront, not the show, so we do not guess.

Reach

58

Percentile among shows you could realistically get on. Not a download count.

Check whether they charge. Some shows sell guest slots rather than booking them, and rates in some fields run to thousands. Nothing in a podcast feed reliably says so, so we do not claim either way. Ask before you write the pitch.

Worth a pitch. This show publishes its own contact, sits outside the national chart, is independently published, and its recent episodes show it books guests.

What the show says about itself

A weekly intelligence download covering the latest developments in AI and biotechnology, designed for pharma and biotech executives navigating the future of drug development. We educate and entertain by summarizing news and analysis of AI-driven drug discovery, biotech investments, M&A activity, and emerging technologies shaping the industry. Going beyond the headlines, we transform complex developments into actionable strategic intelligence, identifying the signals that matter and revealing how they could shape the next generation of therapies, companies, and healthcare innovation.

Recent episodes

Straight from the feed. The quickest way to judge whether your angle fits.

The Biotech Trust Paradox: What Algorithms Must Prove To The Regulators Before They Predict
$2.5B Platform Designed by AI, FDA codifies AI-in-the-loop & Hyper Scalers Jump in
Zero FDA Approvals - The reality of algorithmic drug design
Biotech M&A - A Quarter Trillion dollar bet and 6.8B Proteins released
Death of Manual Biotech - Fully autonomous science got Real with 'Robin', Space Tech meets Biotech, Isomorphic's $2.1B Raise, NVIDIA's $1B P
Lilly's $2.25B bet - Biotech AI Model Stack Structural Shift Lilly- Profluent AI-designed gene editor, OpenAI's GPT-Rosalind with Amgen, Nov

This show publishes a contact

We hold the address this show publishes in its own feed. Addresses and drafted pitches are part of a plan. Browsing stays free, and we never send on your behalf.

Tell me when pitching opens